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Spinal cord injury (SCI) is a major health burden and currently there is no effective medical
intervention. Research performed over the last decade revealed that cells surrounding the
central canal of the adult spinal cord and forming the ependymal layer acquire stem cell
properties either in vitro or in response to injury. Following SCI activated ependymal cells
generate progeny cells which migrate to the injury site but fail to produce the appropriate
type of cells in sufficient number to limit the damage, rendering this physiological response
mainly ineffective. Research is now focusing on the manipulation of ependymal cells to
produce cells of the oligodendrocyte lineage which are primarily lost in such a situation
leading to secondary neuronal degeneration. Thus, there is a need for a more focused
approach to understand the molecular properties of adult ependymal cells in greater detail
and develop effective strategies for guiding their response during SCI.
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Neural stem cells (NSCs) are specialized progenitor cells that can
self-renew and generate both neurons and glia in the central
nervous system (CNS). The first isolation of NSCs from adult
brain lunched a new field of studies in neuroscience (Doetsch
et al., 1997, 1999; Johansson et al., 1999). Adult somatic stem
cells in general contribute to tissue homeostasis in all organ-
isms as they support on-going tissue regeneration, replacing cells
lost due to natural cell death or injury (Pellettieri and Sanchez
Alvarado, 2007). Their function is required throughout life and
their number needs to be maintained through a balance between
self-renewal and differentiation. The underlying mechanisms that
control this delicate balance are fundamental to understanding
stem cell regulation and the therapeutic use of stem cells in
human disease.
Adult NSCs have now been discovered in the two principal
neurogenic regions, the hippocampus and the sub-ventricular
zone (SVZ) of the forebrain (Doetsch et al., 1997; Bonaguidi et al.,
2012). Their discovery raised the possibility that the CNS har-
bors regenerative power. The principal function of SVZ stem cells,
however, is to replace lost neurons in the olfactory epithelium,
while hippocampal stem cells are involved in memory.
The spinal cord in mammals is the least complex component
of the CNS. In adult mice neurogenesis is not taking place. Only
myelinating Oligodendrocytes (OLs) are produced from OL pro-
genitors (OLPs) scattered throughout the parenchyma (Miller,
2002). Several studies in mice and humans confirmed that cells
lining the central canal of the spinal cord, forming the ependymal
layer, have stem cell properties in vitro and thus can generate mul-
tipotent neurospheres in culture (Weiss et al., 1996; Johansson
et al., 1999; Dromard et al., 2008; Alfaro-Cervello et al., 2012;
Bauchet et al., 2013). Under physiological conditions these cells
are effectively quiescent and some proliferation that is taking
place is restricted to ependymal cells located mainly on the dor-
sal tip of the central canal (numbering no more than 4–5 cells
per 10µM) (Meletis et al., 2008; Barnabe-Heider et al., 2010).
During postnatal development, symmetric divisions of ependy-
mal cells contribute to the elongation of the canal (Sabourin
et al., 2009; Alfaro-Cervello et al., 2012). Likewise, adult ependy-
mal cells divide symmetrically but all daughter cells remain in
the ependyma, suggesting that their primary role in adults is
ependymal cell maintenance (Barnabe-Heider et al., 2010).
While all NSCs in the SVZ of the forebrain express the stem
cell markers Nestin, Sox2 and GFAP, in the spinal cord only dor-
sally situated ependymal cells express Nestin/GFAP, while Sox2 is
expressed in all ependymal cells (Sabourin et al., 2009; Barnabe-
Heider et al., 2010; Alfaro-Cervello et al., 2012). This implies
that ependymal cells are most likely heterogeneous in their
NSC potential and that dorsally positioned ependymal cells may
possess different properties. Nevertheless, lineage tracing exper-
iments have conclusively shown that all neurosphere-forming
capacity in the adult spinal cord originates from ependymal
cells with no evidence of sub-ependymal cell contribution but is
unclear whether all spinal cord ependymal cells have equivalent
stem cell potential (Barnabe-Heider et al., 2010).
The fact that embryonic ependymal cells proliferate and con-
tribute to canal elongation, while adult ones are effectively quies-
cent, raises the possibility that the properties of ependymal cells in
new-borns are likely to be different than those in adults. Indeed,
in a limited search for the expression of some transcription fac-
tors in the spinal cord, we found that GATA3 is expressed in a
dynamic manner in ependymal cells of the spinal cord as matu-
ration proceeds and is not expressed in ependymal cells of other
ventricles (data not shown). It is also intriguing that the Gata3
gene has never been found to be expressed in any CNS pro-
genitors but only in some differentiated neurons. In the spinal
cord, Gata3 is expressed in V2b interneurons and its expression
is regulated by Notch signaling (Del Barrio et al., 2007). Notch
signaling plays a critical role in the ontogeny of forebrain ependy-
mal cells (Carlen et al., 2009) but less is known about its function
on the ontogeny of spinal cord ependymal cells. Nevertheless,
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the fact that there are differences between these two ependy-
mal cell populations makes the investigation of the molecular
properties of the spinal cord ependymal cells more intriguing.
Furthermore, the two populations respond differently in situa-
tions of injury. In stroke induced injury, ependymal cells enter the
cell cycle and become depleted (Carlen et al., 2009) whereas, after
spinal cord injury (SCI), ependymal cells proliferate and their
progeny becomes recruited to the injured site leaving behind an
intact ependymal layer (Meletis et al., 2008; Barnabe-Heider et al.,
2010). Such unique molecular characteristic of the spinal ependy-
mal cells could prove important in modulating their response in
situations of injury.
EPENDYMAL CELLS BECOME ACTIVATED FOLLOWING
SPINAL CORD INJURY
SCI is a major cause of irreversible paralysis and currently there
are no effective treatments. Several studies have shown that
in vitro expanded neural progenitors derived from ependymal
stem cells, when implanted into the injured site, can contribute
to the formation of functional neuronal circuits in experimental
models. Furthermore, the transplantation of spinal cord-derived
neural progenitors promotes functional recovery (Hofstetter
et al., 2005). Such recovery is much enhanced when myelinating
progenitors are used [reviewed by Franklin and Ffrench-Constant
(2008)]. However, exogenous administration of neural progeni-
tors is not a process that has so far shown great promise not only
due to the technical complications involved but also due to safety
issues stemming from dangers in relation to the fate of implanted
cells and the risk of carcinogenesis.
Despite the quiescent existence of ependymal cells under nor-
mal conditions, in models of SCI they increase significantly their
proliferation rate and their progeny get recruited to the injured
site. Indeed, following SCI, the neurosphere-forming capacity
of ependymal cells is greatly enhanced (Meletis et al., 2008;
Barnabe-Heider et al., 2010). Thus, the activation of endoge-
nous stem/progenitor cells after injury or neural degeneration is
another approach to reduce the effects of neuronal damage. This
view is reinforced by the fact that ependymal cells are only a few
millimeters away from any injured site and fast migration of their
progeny may prove effective for self-repairing the injury.
In the uninjured spinal cord the vast majority of prolifer-
ating cells represent OLPs. Following SCI, ependymal cells and
astrocytes become activated to a much higher degree than OLPs
(Barnabe-Heider et al., 2010). Despite the multilineage potential
of activated ependymal cells in vitro, the progeny generated in vivo
following SCI is restricted to mainly glial cells the vast major-
ity of which represent GFAP−ve astrocytes, as shown by Sox9
expression. Newly formed ependymal-derived astrocytes migrate
primarily to the center of the lesion site leading to the formation
of the glial scar, which prevents axon regeneration. OLPs give rise
only to OLs (Barnabe-Heider et al., 2010).
SCI results in rapid loss of OLs leaving many axons partly
denuded leading to loss of impulse propagation. In partial SC
lesions, which are more common, the loss of OLs leads to
secondary neurological dysfunction and neuronal degeneration
(Grossman et al., 2001; Lytle andWrathall, 2007). The adult spinal
cord microenvironment has strong progliogenic cues and pre-
vents effective neuronal differentiation even when spinal cord
stem cells engineered to favor neurogenesis are transplanted in
the injured cord (Hofstetter et al., 2005). Infusion of growth fac-
tors, such as EGF and FGF2, into the central canal is able to
increase the proliferation of ependymal cells and improve func-
tional recovery after SCI (Kojima and Tator, 2002; Martens et al.,
2002), suggesting that manipulation of endogenous ependymal
cells may alter their differentiation potential. Nevertheless, the
most attractive approach is to develop strategies for effective
remyelination following SCI. The goal should, therefore, be to
use current knowledge on OL development and specification to
either limit the damage to OLs or modulate endogenous activa-
tion of ependymal cells toward generating more OL to replenish
those lost.
Most approaches for therapies following SCI concentrate on
limiting inflammation and secondary cell death, while at the same
time promoting the restoration of functional circuits. In experi-
mental SCI models, axonal regrowth can be enhanced through
the administration of Brain-derived neurotrophic factor (BDNF),
an agent that promotes axonal regrowth, possibly by recruiting
myelinating OLs [reviewed by Weishaupt et al. (2012)]. More
recently a study has shown that by interfering with the interaction
between proNGF and p75 using a small, non-peptide, molecule
named LM11A-3 prevented OL loss, increased the number of
myelinating axons and improved functional recovery in an exper-
imental model of SCI. Importantly this molecule can cross the
blood-brain barrier without obvious toxicity complications (Tep
et al., 2013).
In parallel to pharmacological manipulation of specific type of
cells to limit functional impairment, the modulation of endoge-
nously recruited ependymal-derived cells toward the OL lineage
either using genetic engineering or by pharmacological means
has not yet been reported. The fast-growing knowledge on glial
cell specification during embryonic development should aid in
this direction. For instance, the study of the regulation of the
expression of the transcription factor OLIG2 in adult spinal cord
could prove very useful in this regard. OLIG2 is not expressed
in ependymal cells but only in OLPs scattered throughout the
parenchyma (Meletis et al., 2008; Sabourin et al., 2009). OLIG2 is
necessary and sufficient to drive OLP specification in the embry-
onic cord. Consequently, loss of OLIG2 leads to the conversion
of prospective OLPs to Astrocyte progenitors suggesting that, at
least in the embryonic spinal cord, OLIG2 regulates the fate of
otherwise bi-potent glial progenitors (Lu et al., 2002; Zhou and
Anderson, 2002; Liu et al., 2007). Since OLIG2 is not expressed
in ependymal cells, the activation of this gene (or downstream
target genes) in ependymal cells following SCI could provide
insights into the ability of the latter to contribute to the formation
of myelinating OLs in sufficient numbers to improve functional
recovery. Indeed, some studies in the adult brain have shown that
intraventricular administration of known pro-Oligogenic factors
in the embryo (Lu et al., 2002) can enhance OL specification from
stem cells demonstrating that pharmacological manipulation of
ependymal cells is a viable option for ameliorating the effects
of SCI. Furthermore, in the acute experimental autoimmune
encephalomyelitis (EAE) animal model for Multiple Sclerosis,
priming of NSC to become OLPs by overexpression of OLIG2
resulted in improvement of clinical symptoms following intra-
ventricular delivery of the engineered NSCs (Sher et al., 2012).
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In summary, several studies on the properties and behavior of
ependymal cells in models of SCI have converged on to a number
of findings that could pave the way for more effective therapies.
Of major importance is the recruitment of a large number of
ependymal-derived cells at the injury site while at the same time
maintaining the ontogeny of the canal. Equally important is the
fact that the astrocytes produced are positioned in the center
of the glial scar opening the way for a more targeted approach
to manipulate the fate of activated ependymal cells. Crucial in
these efforts is to develop strategies for initiating remyelination
at the injury site by manipulating the fate of cells produced from
activated central canal stem cells. Forcing these cells to initiate
a pro-oligogenic pathway of glial specification should be at the
center of future experimentation. Such effort should be aided
through combined approaches using knowledge from embryonic
development and cellular responses following tissue damage in
SCI conditions. It is likely that in the next few years we will be
confronted with exciting developments that will open the way for
clinical trials to treat SCI.
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